Differential response of iron metabolism to oxidative stress generated by antimycin A and nitrofurantoin

Biochimie
Brigitte SturmBarbara Scheiber-Mojdehkar

Abstract

The close interrelationship of oxidative stress and iron is evident by the influence of intracellular reactive oxygen species on iron metabolism. Oxygen radicals can lead to release of iron from iron-sulfur proteins and ferritin, and can damage iron-containing enzymes such as mitochondrial aconitase. Treatment of HepG2 human hepatoma cells with antimycin A has two effects relating to iron depending on the concentrations of antimycin A: increase of the labile iron pool and stimulation of non-transferrin-bound iron uptake. Whereas the first could also be generated with nitrofurantoin, the stimulation of non-transferrin-bound iron uptake was only seen with antimycin A and needed considerably higher concentrations. Pretreatment of the cells with ebselen, which scavenges peroxides, reverted only the effect of nitrofurantoin on the labile iron pool. Depletion with iron chelators before or after treatment with antimycin A diminished the stimulation of non-transferrin-bound iron uptake. We conclude that the generation of oxygen radicals in the mitochondria leads to the liberation of iron from mitochondrial enzymes, which enters the labile iron pool. But high concentrations of antimycin A leading to the stimulation of non-transferrin-bo...Continue Reading

References

Aug 15, 1992·Journal of Inorganic Biochemistry·L C Kühn, M W Hentze
Jan 1, 1992·Critical Reviews in Toxicology·T P Ryan, S D Aust
Aug 1, 1991·American Journal of Clinical Pathology·R L HamillB A Cook
Jun 7, 1991·Biochimica Et Biophysica Acta·D Richardson, E Baker
Jan 1, 1990·Methods in Enzymology·B Halliwell, J M Gutteridge
Jan 1, 1987·Annual Review of Nutrition·V R GordeukG M Brittenham
Aug 15, 1988·Biochemical Pharmacology·L RossiP J O'Brien
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·C M CravenJ Kaplan
Jun 2, 1995·The Journal of Biological Chemistry·P R GardnerC W White
Apr 1, 1994·Journal of Clinical Pathology·P HarrisonD Bareford
Sep 1, 1995·In Vitro Cellular & Developmental Biology. Animal·V NeumannovaJ Kovar
Feb 15, 1996·Archives of Biochemistry and Biophysics·B Scheiber, H Goldenberg
Sep 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·G CairoA Bernelli-Zazzera
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·K Keyer, J A Imlay
Jan 1, 1997·Free Radical Biology & Medicine·M DürkenA R Zander
Dec 31, 1997·British Journal of Haematology·S J BradleyJ B Porter
Jul 31, 1998·Analytical Biochemistry·L Brunner-DöpperH Goldenberg
Mar 20, 1999·Kidney International. Supplement·J W Eschbach, J W Adamson
Sep 7, 1999·Journal of the American Society of Nephrology : JASN·A BesarabJ Yee
Dec 3, 1999·The International Journal of Biochemistry & Cell Biology·N C Andrews
Jul 19, 2002·Journal of Neurochemistry·Claudia Núñez-MillacuraMarco T Núñez

❮ Previous
Next ❯

Citations

Mar 27, 2013·Parasitology Research·Valesca AnschauLuiz Claudio Miletti
Jan 22, 2008·Free Radical Biology & Medicine·Yun WangJeffrey D Laskin
Jul 1, 2020·Free Radical Biology & Medicine·Helmut Sies, Michael J Parnham

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.